More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects.
about
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea.Overview of randomized controlled treatment trials for clinically localized prostate cancer: implications for active surveillance and the United States preventative task force report on screening?Low risk prostate cancer in men under age 65: the case for definitive treatment.Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England.Imaging modalities for prostate cancer.18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.Gleason inflation 1998-2011: a registry study of 97,168 men.Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram.A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection.Obesity and cancer
P2860
Q34644401-90DDF0E6-B258-4C45-A17C-9342E70F7277Q36011880-1C640166-2A01-48D6-B751-B7B776D90404Q36374511-BB67CF30-AA30-4A92-A02C-69C9F9D73145Q36520539-D8B64F26-0E8A-4D73-B1B3-6D2DDFCC8700Q37019380-46D52EDA-0D87-4C88-A6B9-2424B322A2C6Q37104344-B9833881-4212-4E63-B350-0BCFA16D8B09Q37235605-D85A529E-22E0-42A8-9D3D-EC95B6DBC7D6Q37546036-BC0AE506-EDAC-4E9A-A45E-B95F6FF3D620Q37918311-9A187347-ED6C-4090-B68C-ED444855FEBEQ39199397-BC3E3CDC-CA88-4EFF-BBC5-D69316A4A961Q39476138-B0387FCD-ADC5-48D5-96D3-7FAFC4A634A6Q53093666-EEABD358-4E1D-4F71-92B7-984BA44D6590Q56988184-B1AEE5A6-0D23-4691-A67C-E1D77CA48FE9
P2860
More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
More favorable tumor features ...... nd threshold-specific effects.
@en
More favorable tumor features ...... nd threshold-specific effects.
@nl
type
label
More favorable tumor features ...... nd threshold-specific effects.
@en
More favorable tumor features ...... nd threshold-specific effects.
@nl
prefLabel
More favorable tumor features ...... nd threshold-specific effects.
@en
More favorable tumor features ...... nd threshold-specific effects.
@nl
P2093
P1433
P1476
More favorable tumor features ...... nd threshold-specific effects.
@en
P2093
Kimberly A Roehl
Sheila A Hawkins
Thomas L Jang
William J Catalona
P304
P356
10.1016/J.UROLOGY.2005.08.048
P407
P577
2006-01-25T00:00:00Z